Trials / Completed
CompletedNCT04984083
Maternal and Neonatal Benefits of Prophylactic Administration of Vitamin K Before Elective Cesarean Section
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- National Research Centre, Egypt · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Vitamin K deficiency can cause serious risks to pregnant women and their babies that may lead to hemorrhage, especially in newborns. We aim to evaluate the efficacy of vitamin k in decreasing blood loss during and after elective cesarean section (CS), and to assess the neonatal beneficial effects of prophylactic maternal vitamin k administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | vitamin k | patients will take vitamin k 10 mg/ml once daily orally or IM between four and 96 hours before elective cesarean section |
Timeline
- Start date
- 2021-07-30
- Primary completion
- 2021-10-01
- Completion
- 2021-12-31
- First posted
- 2021-07-30
- Last updated
- 2022-02-15
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04984083. Inclusion in this directory is not an endorsement.